Recognition of tumor glycans by antigen-presenting cells
about
Targeting C-Type Lectin Receptors for Cancer ImmunitySynthesis and evaluation of a desymmetrised synthetic lectin: an approach to carbohydrate receptors with improved versatility.Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumoursInflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis.Molecular factors in dendritic cell responses to adsorbed glycoconjugates.Integrative analysis workflow for the structural and functional classification of C-type lectins.The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway.Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages.The immunomodulating roles of glycoproteins in epithelial ovarian cancer.Dendritic cells respond to nasopharygeal carcinoma cells through annexin A2-recognizing DC-SIGN.Signaling by myeloid C-type lectin receptors in immunity and homeostasisMyeloid C-type lectins in innate immunity.Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells.Tumors: too sweet to remember?Specific Dioscorea Phytoextracts Enhance Potency of TCL-Loaded DC-Based Cancer Vaccines.Enhanced immune recognition of cryptic glycan markers in human tumors.Peptide-based vaccines for cancer: realizing their potential.Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses.Inflammation and arthritis: perspectives of the glycobiologist.Plasma Anti-Glycan Antibody Profiles Associated with Nickel level in Urine.Human C-type lectin domain family 4, member C (CLEC4C/BDCA-2/CD303) is a receptor for asialo-galactosyl-oligosaccharides.A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination.Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer.Gene expression changes in immune response pathways following oral administration of tetrabromobisphenol A (TBBPA) in female Wistar Han rats.Investigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancer.A Synthetic MUC1 Anticancer Vaccine Containing Mannose Ligands for Targeting Macrophages and Dendritic Cells.Type and maturational status of dendritic cells in cutaneous B cell lymphoproliferative disorders
P2860
Q26784483-8747D4F3-8058-461E-BB8E-D444A8DF79E7Q31038126-EA24991E-7849-46D6-93FA-22278A93AAB0Q33276145-618401F9-C60B-4070-9AA0-A9A9BD496693Q33811691-44D6277D-BD33-4A7B-8B15-7FEDADA61B0CQ34024402-F207810F-20AC-495A-9715-D9DDBA3AAA32Q34175124-AF874068-AFC0-468B-8844-5D951C6966E7Q34303768-872740F2-A626-49BF-AB93-129BE4EE58EAQ34571570-1FDB31F4-7E1F-4739-B5A3-D5A40292300DQ35077893-22EF0C97-0B06-4321-9E92-ED0068575797Q35238416-1F39276D-DD7B-4CCB-85F0-395B5D7E9CFDQ35779708-6B9B021F-EE3B-4FFA-A767-F74ADE207585Q36655901-A298CC50-358C-4216-B149-19CB3EDA5CBBQ36742670-94D28922-3DE2-4CEE-BC5B-6612D25AF4F5Q36962406-AABAEAA6-ED7E-4366-A117-02A444721083Q37021511-52C7DC52-D03F-4771-B2D4-114AA0245104Q37045125-8782CE7F-B0A4-4AF1-A429-064C811F128FQ37133417-6DF1C5A4-DE04-4A0A-984F-0F88C48AFE9CQ37340462-44FCDB08-3BF4-400E-A184-C5392E7C8727Q37598949-19E49FA7-5BA3-4DB5-8FE4-3390F9878159Q37754703-67ECD3F9-1803-4816-BE94-F2E36952B865Q38724225-0AA3F712-0099-4E0A-B448-917D08A8B712Q38734990-3C8D79CF-08CE-412E-A895-AA95CA2FC1A0Q38832639-D8DAB333-5697-4071-91DD-AEDFE74C1606Q39373538-A98B98E4-5351-42F1-A445-9BD6144C3181Q39999722-8F7D6DCE-6688-45D7-BFC9-3DAB86118DA2Q40452707-6C574772-79A9-4E2E-8911-A0C7664D8905Q41876001-A06A2173-3D06-475F-8803-9127CC466B99Q49377125-8B454231-DD1D-47BB-94CD-8590E688FE42Q58001493-359F216D-9B1D-444F-9722-2A8096D27B9D
P2860
Recognition of tumor glycans by antigen-presenting cells
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Recognition of tumor glycans by antigen-presenting cells
@ast
Recognition of tumor glycans by antigen-presenting cells
@en
Recognition of tumor glycans by antigen-presenting cells
@nl
type
label
Recognition of tumor glycans by antigen-presenting cells
@ast
Recognition of tumor glycans by antigen-presenting cells
@en
Recognition of tumor glycans by antigen-presenting cells
@nl
prefLabel
Recognition of tumor glycans by antigen-presenting cells
@ast
Recognition of tumor glycans by antigen-presenting cells
@en
Recognition of tumor glycans by antigen-presenting cells
@nl
P2093
P3181
P1476
Recognition of tumor glycans by antigen-presenting cells
@en
P2093
Corlien A Aarnoudse
Eiríkur Saeland
Yvette van Kooyk
P304
P3181
P356
10.1016/J.COI.2005.11.001
P407
P577
2005-11-21T00:00:00Z